Al-Ali Naif, Cheema Rizwan A, Abdelaziz Medhat A, Khattak Ashbala
Cornea Division, Dhahran Eye Specialist Hospital, Dhahran, KSA.
Retina Division, Dhahran Eye Specialist Hospital, Dhahran, KSA.
Saudi J Anaesth. 2014 Nov;8(Suppl 1):S63-6. doi: 10.4103/1658-354X.144080.
To evaluate effect on intraocular pressure (IOP) during sub-Tenon's local anesthesia (LA) during cataract surgery with 4 ml of anesthetic injected without and with addition of hyluronidase to anesthetic solution.
This randomized controlled study included 65 eyes of 65 patients undergoing phacoemulsification and lens implant for cataract. The patients were randomized to a standardized procedure of administration of 4 ml of sub-Tenon's LA without and with addition of 15 IU/ml hylaluronidase to 2% lidocaine (control group and intervention group respectively). IOP measurements were carried out immediately prior to and at 2, 5, and 10 and 15 min after sub-Tenon's injection using a hand held tonometer (Tonopen).
All patients achieved satisfactory akinesia and complete analgesia during surgery. The mean age of patients in control group was 59.56 ± 14.3 years, and 61.77 ± 11.91 years in intervention group (P = 0.507). The mean preinjection and 15 min IOP was 19.16 ± 4.39 and 20.21 ± 5.49 mm Hg, respectively in control group (P = 0.220); and 19.81 ± 3.8 and 19.68 ± 5.19 mmHg respectively in intervention group (P = 0.911). No statistical difference from baseline was detected between preinjection and at 2, 5, 10, and 15 min after injection in control (P = 0.124, 0.310, 0.804, 0.220, respectively) and intervention group (P = 0.367, 0.879, 0.765, 0.911 respectively).
No significant rise in IOP occurs following injection of sub-Tenon's LA, when up to 4 ml of anesthetic is injected. The addition of hyaluronidase to 2% lignocaine has no beneficial lowering effect on IOP in sub-Tenon's LA. Hence, the practice of addition of this agent may not be necessary during cataract surgery.
评估在白内障手术中,于球结膜下局部麻醉(LA)时,在麻醉溶液中不添加和添加透明质酸酶的情况下注入4毫升麻醉剂对眼压(IOP)的影响。
这项随机对照研究纳入了65例接受白内障超声乳化和晶状体植入手术患者的65只眼睛。患者被随机分为两组,分别接受标准化程序的球结膜下局部麻醉,一组在2%利多卡因中不添加透明质酸酶注入4毫升(对照组),另一组在2%利多卡因中添加15 IU/ml透明质酸酶注入4毫升(干预组)。使用手持眼压计(Tonopen)在球结膜下注射前以及注射后2、5、10和15分钟测量眼压。
所有患者在手术期间均获得了满意的眼球运动麻痹和完全镇痛效果。对照组患者的平均年龄为59.56±14.3岁,干预组为61.77±11.91岁(P = 0.507)。对照组注射前和15分钟时的平均眼压分别为19.16±4.39和20.21±5.49 mmHg(P = 0.220);干预组分别为19.81±3.8和19.68±5.19 mmHg(P = 0.911)。对照组注射前与注射后2、5、10和15分钟之间以及干预组注射前与注射后2、5、10和15分钟之间均未检测到与基线的统计学差异(对照组分别为P = 0.124、0.310、0.804、0.220;干预组分别为P = 0.367、0.879、0.765、0.911)。
在球结膜下局部麻醉注射时,当注入多达4毫升麻醉剂时,眼压不会显著升高。在球结膜下局部麻醉中,向2%利多卡因中添加透明质酸酶对眼压没有有益的降低作用。因此,在白内障手术期间可能没有必要添加这种药物。